The immunobiology of humanized Anti-IL6 receptor antibody: From basic research to breakthrough medicine-Reference-Cited by-同舟云学术

The immunobiology of humanized Anti-IL6 receptor antibody: From basic research to breakthrough medicine

Published:2020 Issue: Volume:3 Page:100030
ISSN:2589-9090
Container-title:Journal of Translational Autoimmunity
language:en
Short-container-title:Journal of Translational Autoimmunity

Author:

Ohsugi Yoshiyuki

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference58 articles.

1. Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases;Ohsugi;Biol. Pharm. Bull.,2007

2. The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis;Ohsugi;Expert Opin. Biol. Ther.,2008

3. Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity;Chen;J. Autoimmun.,2017

4. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis;Blauvelt;Clin. Rev. Allergy Immunol.,2018

5. Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients;Yokota;Clin. Exp. Rheumatol.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-inflammatory and/or immunomodulatory activities of Uncaria tomentosa (cat’s claw) extracts: A systematic review and meta-analysis of in vivo studies;Frontiers in Pharmacology;2024-05-31

2. Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach;International Immunopharmacology;2022-10

3. Interleukin-6, a major player of cytokine storm in COVID-19 and its alleviation by therapeutic antibodies;Current Science;2022-09-25

4. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series;Seizure;2022-08

5. Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6?;Biomedicines;2022-01-29